ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Top 10 Challenges And Solutions For Decentralized Clinical Trials

  Decentralized clinical trials are reshaping research, but what are the biggest roadblocks to their full potential? We delve into the top 10 challenges and the cutting-edge solutions emerging.

• Reduce Workloads And Improve Insights With Crowdsource UAT

  Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

• Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development

  In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.

• How TrialKit's API Architecture Enables Custom Clinical Workflows Without Added Complexity

  Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.

• From Months To Hours: MMC Medical's EDC Revolution

  Learn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.

• Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection

  Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.

• Deconstructing Central Rating In Clinical Trials

  Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this

• 5 Benefits Of Using A Study Management Tool

  See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• To Counter Bias, Counterbalance

  It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.